None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -A patient aged 19 years or older who was diagnosed with acute coronary syndrome and was scheduled for coronary intervention with Genoss stent. -Patients who voluntarily decided to participate in this study and consented in writing to the subject consent
Exclusion criteria
Exclusion criteria: - Patients with contraindications or hypersensitivity to antiplatelet therapy - Life expectancy is less than one year - Women who are pregnant or wishing to become pregnant or women who are breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rates of 1-year target-lesion failure (composite of cardiac death, target-vessel myocardial infarction [TV-MI], and ischemic-driven target lesion revascularization [ID-TLR]) | — |
Secondary
| Measure | Time frame |
|---|---|
| The rate of 1-year non-cardiac death;The rate of 1-year non-TV-MI;The rate of 1-year non-ID-TLR;The rate of 1-year cardiac death;The rate of 1-year major adverse cardiac events(MACE) (composite of all-death, all-MI, all-TLR);The rate of 1-year TV-MI;The rate of 1-year ID-TLR;The rate of acute(<24 hr), subacute(<30 day), late(<1 year) stent thrombosis;The success rate of percutaneous coronary intervention | — |
Countries
Korea, Republic of
Contacts
Yonsei University Yongin Severance Hospital